Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 314.19 Million CNY | -16.59% |
| 2022 | 671.1 Million CNY | 27.87% |
| 2021 | 524.82 Million CNY | 157.37% |
| 2020 | 203.91 Million CNY | 74.96% |
| 2019 | 116.55 Million CNY | 40.86% |
| 2018 | 82.74 Million CNY | 16.18% |
| 2017 | 71.22 Million CNY | 17.0% |
| 2016 | 60.87 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 91.92 Million CNY | -21.43% |
| 2024 Q2 | 94.66 Million CNY | 14.96% |
| 2024 Q1 | 82.34 Million CNY | -58.55% |
| 2023 Q1 | 94.19 Million CNY | -56.82% |
| 2023 FY | 559.78 Million CNY | -16.59% |
| 2023 Q4 | 198.64 Million CNY | 94.81% |
| 2023 Q3 | 101.96 Million CNY | 154.16% |
| 2023 Q2 | 40.11 Million CNY | -57.41% |
| 2022 Q1 | 143.55 Million CNY | -8.59% |
| 2022 Q2 | 98.6 Million CNY | -31.31% |
| 2022 Q4 | 218.12 Million CNY | 3.46% |
| 2022 Q3 | 210.81 Million CNY | 113.8% |
| 2022 FY | 671.1 Million CNY | 27.87% |
| 2021 Q3 | 77.79 Million CNY | -57.93% |
| 2021 Q2 | 184.9 Million CNY | 75.98% |
| 2021 Q1 | 105.07 Million CNY | 4.05% |
| 2021 FY | 524.82 Million CNY | 157.37% |
| 2021 Q4 | 157.05 Million CNY | 101.89% |
| 2020 Q4 | 100.98 Million CNY | 172.42% |
| 2020 FY | 203.91 Million CNY | 74.96% |
| 2020 Q1 | 30.08 Million CNY | -7.59% |
| 2020 Q3 | 37.06 Million CNY | 3.63% |
| 2020 Q2 | 35.76 Million CNY | 18.88% |
| 2019 FY | 116.55 Million CNY | 40.86% |
| 2019 Q3 | 29.54 Million CNY | 14.53% |
| 2019 Q2 | 25.79 Million CNY | -9.98% |
| 2019 Q1 | 28.65 Million CNY | 123.62% |
| 2019 Q4 | 32.56 Million CNY | 10.22% |
| 2018 Q3 | 25.02 Million CNY | 0.0% |
| 2018 FY | 82.74 Million CNY | 16.18% |
| 2018 Q4 | 12.81 Million CNY | -48.79% |
| 2018 Q1 | 20.88 Million CNY | 0.0% |
| 2017 FY | 71.22 Million CNY | 17.0% |
| 2016 FY | 60.87 Million CNY | 0.0% |